Elle DigestLifestyle, beauty and consumer releases

Press Release · Xtalks

Underneath the Lost Kilos: Adipose, Adiposity and Adiposopathy, Upcoming Webinar Hosted by Xtalks

Distributed by Elle Digest · Originally issued via PR Newswire

www.antarosmedical.com

In this free webinar, learn how adipose tissue biology and dysfunction can inform obesity and metabolic disease drug development. The featured speakers will discuss adiposity, adiposopathy and how adipose tissue changes with weight loss and treatment, including shifts in volume, distribution, composition, and function. Attendees will also explore body composition assessment methods and emerging questions around the links between adipose tissue and treatment response, sex differences and overall metabolic health.

TORONTO, Nov. 17, 2026 — There is growing pressure for therapeutics to demonstrate meaningful health benefits beyond the traditional weight loss efficacy metrics. For example, body composition assessments are increasingly used as evidence of "quality" weight loss, demonstrating that weight loss comes preferentially from fat loss.

www.antarosmedical.com

At the centre of obesity, type 2 diabetes and various other metabolic diseases are adipose tissue excess (adiposity) and adipose tissue dysfunction (adiposopathy). Previously thought of as a passive energy store, adipose tissue is now recognized as a dynamic, metabolically active endocrine organ with many important functions. Adipose tissue expansion, distribution and dysfunction affect overall metabolic health, individual tissue function and a range of related conditions.

In this webinar, the featured speakers will discuss and explore adipose tissue function and dysfunction, addressing key questions including:

  • What is currently understood about adipose tissue biology and how it changes in disease states such as obesity and type 2 diabetes?
  • How does adipose tissue change with weight loss and treatment? How are volumetric reduction, spatial distribution and plasticity/composition changes linked to metabolic improvements, overall health benefits and response to therapy?
  • How can adipose tissue health help explain response variability, sex-specific differences and the heterogeneity of obesity as a disease?

Register for this webinar to learn more about adipose tissue, how it changes during weight loss and with treatment and its relevance within metabolic disease drug development.

Join Kirsi Pietiläinen, Professor of Clinical Metabolism, University of Helsinki; and Lars Johansson, Chief Scientific Officer, Antaros Medical, for the live webinar on Monday, December 7, 2026, at 11am EST (5pm CET / EU-Central).

For more information, or to register for this event, visit Underneath the Lost Kilos: Adipose, Adiposity and Adiposopathy.

Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: [email protected]

SOURCE Xtalks

ABOUT XTALKS

Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.

Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.

To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/